Currently out of the existing stock ratings of Kalpit Patel, 107 are a BUY (81.68%), 23 are a HOLD (17.56%), 1 are a SELL (0.76%).

Kalpit Patel

Work Performance Price Targets & Ratings Chart

Analyst Kalpit Patel, currently employed at WOLFE, carries an average stock price target met ratio of 37.75% that have a potential upside of 31.94% achieved within 129 days. Previously, Kalpit Patel worked at CREDIT SUISSE, 2924.0, B. RILEY, B. RILEY.

Kalpit Patel’s has documented 242 price targets and ratings displayed on 30 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on VSTM, Verastem at 16-Sep-2026.

Wall Street Analyst Kalpit Patel

Analyst best performing recommendations are on VSTM (VERASTEM).
The best stock recommendation documented was for VSTM (VERASTEM) at 12/30/2024. The price target of $7 was fulfilled within 4 days with a profit of $3.33 (90.74%) receiving and performance score of 226.84.

Average potential price target upside

BCYC Bicycle Therapeutics Ltd INFI Infinity Pharmaceuticals INKT Mink Therapeutics KYMR Kymera Therapeutics MGTA Magenta Therapeutics RIGL Rigel Pharmaceuticals FBRX Forte Biosciences ALLO Allogene Therapeutics ENTX Entera Bio Ltd INAB In8bio VINC Vincerx Pharma MRTX Mirati Ther DERM Journey Medical Corp GERN Geron VRDN Viridian Therapeutics SNDX Syndax Pharmaceuticals LBPH Longboard Pharmaceuticals CRBP Corbus Pharmaceuticals PDSB PDS Biotechnology Corp VSTM Verastem XFOR X4 Pharmaceuticals OVID Ovid Therapeutics AVBP ArriVent BioPharma, Common Stock MG Mistras Group CELC Celcuity LLC CORT Corcept Therapeutics FHTX Foghorn Therapeutics RVMD Revolution Medicines SLNO Soleno Therapeutics SRRK Scholar Rock Holding Corp

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 02-Mar-2022

$14

$10.62 (314.20%)

$15

2 months 5 days ago
(30-Jul-2026)

0/24 (0%)

$9.99 (249.13%)

Hold Since 15-Feb-2022

$12

$7.9 (192.68%)

5 months 27 days ago
(08-Apr-2026)

0/8 (0%)

$7.02 (140.96%)

Buy Since 12-Jun-2020

$36

$32.62 (965.09%)

$36

6 months 2 days ago
(03-Apr-2026)

3/11 (27.27%)

$30.95 (612.87%)

192

Hold Since 18-Mar-2026

$7

$2.9 (70.73%)

6 months 17 days ago
(18-Mar-2026)

0/3 (0%)

$2.3 (48.94%)

Hold Since 24-Nov-2025

$10

$5.9 (143.90%)

$25

10 months 11 days ago
(24-Nov-2025)

0/5 (0%)

$3.26 (48.37%)

Show more analysts

Please expand the browser size to see the chart

Which stock is Kalpit Patel most bullish on?

Potential upside of $45.15 has been obtained for KYMR (KYMERA THERAPEUTICS)

Which stock is Kalpit Patel most reserved on?

Potential downside of -$66.23 has been obtained for CORT (CORCEPT THERAPEUTICS)

What Year was the first public recommendation made by Kalpit Patel?

On 2021
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?